118th AFDO Conference Evaluation - Tuesday, June 24, 2014

Tuesday, June 24th

Please rate the presentations from the Food/General Session -OR- the Drug/Device Seminar.

Question Title

* 1. Food and General Sessions (in order of appearance):

	Very Good	Good	Fair	Poor	Did Not Attend
MACRO TRENDS AND CONSIDERATION: Clayton Smith	MACRO TRENDS AND CONSIDERATION: Clayton Smith Very Good	MACRO TRENDS AND CONSIDERATION: Clayton Smith Good	MACRO TRENDS AND CONSIDERATION: Clayton Smith Fair	MACRO TRENDS AND CONSIDERATION: Clayton Smith Poor	MACRO TRENDS AND CONSIDERATION: Clayton Smith Did Not Attend
FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner	FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner Very Good	FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner Good	FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner Fair	FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner Poor	FDA – PROGRESS, TRENDS AND COMPLIANCE: Ellen Morrison and Roberta Wagner Did Not Attend
HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski	HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski Very Good	HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski Good	HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski Fair	HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski Poor	HEALTH CANADA – PROGRESS, TRENDS AND COMPLIANCE: Ward Chickoski Did Not Attend
CFIA – Progress, Trends and Compliance: Stephen Baker	CFIA – Progress, Trends and Compliance: Stephen Baker Very Good	CFIA – Progress, Trends and Compliance: Stephen Baker Good	CFIA – Progress, Trends and Compliance: Stephen Baker Fair	CFIA – Progress, Trends and Compliance: Stephen Baker Poor	CFIA – Progress, Trends and Compliance: Stephen Baker Did Not Attend
USDA – Progress, Trends and Compliance: Jerry L. Elliott	USDA – Progress, Trends and Compliance: Jerry L. Elliott Very Good	USDA – Progress, Trends and Compliance: Jerry L. Elliott Good	USDA – Progress, Trends and Compliance: Jerry L. Elliott Fair	USDA – Progress, Trends and Compliance: Jerry L. Elliott Poor	USDA – Progress, Trends and Compliance: Jerry L. Elliott Did Not Attend
Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury	Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury Very Good	Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury Good	Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury Fair	Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury Poor	Funding Opportunities for State, Local, Tribal, and Territorial Retail Food Regulatory Programs: Cathy Hosman and Pete Salsbury Did Not Attend
“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith	“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith Very Good	“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith Good	“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith Fair	“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith Poor	“Establishing Retail Food Safety Policy"- The Federal, State & Local perspective, including the outcomes from the 2014 Conference for Food Protection (CFP): Kevin Smith Did Not Attend
“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara	“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara Very Good	“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara Good	“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara Fair	“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara Poor	“Are things getting better?” Overview of FDA’s Retail Risk Factor Study and the Promotion of Active Managerial Control: Lane Drager and Mario Seminara Did Not Attend
“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart	“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart Very Good	“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart Good	“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart Fair	“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart Poor	“Improving Behaviors on the Front Line” - FDA’s Partnership with Google to Test the Effectiveness of Oral Culture Learner Project Materials: Chuck Catlin and Alan Tart Did Not Attend
Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan	Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan Very Good	Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan Good	Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan Fair	Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan Poor	Methods Development - Case studies on method development, validation and use for regulatory action with and without established FDA tolerance limits: Robert Sheridan Did Not Attend
Quality Laboratory Results: Kristen Durie	Quality Laboratory Results: Kristen Durie Very Good	Quality Laboratory Results: Kristen Durie Good	Quality Laboratory Results: Kristen Durie Fair	Quality Laboratory Results: Kristen Durie Poor	Quality Laboratory Results: Kristen Durie Did Not Attend
Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger	Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger Very Good	Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger Good	Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger Fair	Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger Poor	Update on Sampling agreements between State Laboratories and State Food Safety Programs: Michelle Motsinger Did Not Attend
Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan	Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan Very Good	Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan Good	Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan Fair	Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan Poor	Data and Decisions/Actions based on Common Deficiencies from State Agencies: Natalie Adan Did Not Attend
Wet & Dry Principles & Practices: Warren Stone	Wet & Dry Principles & Practices: Warren Stone Very Good	Wet & Dry Principles & Practices: Warren Stone Good	Wet & Dry Principles & Practices: Warren Stone Fair	Wet & Dry Principles & Practices: Warren Stone Poor	Wet & Dry Principles & Practices: Warren Stone Did Not Attend
Industry Examples of Common Challenges & Deficiencies: Karl Thorson	Industry Examples of Common Challenges & Deficiencies: Karl Thorson Very Good	Industry Examples of Common Challenges & Deficiencies: Karl Thorson Good	Industry Examples of Common Challenges & Deficiencies: Karl Thorson Fair	Industry Examples of Common Challenges & Deficiencies: Karl Thorson Poor	Industry Examples of Common Challenges & Deficiencies: Karl Thorson Did Not Attend
FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes	FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes Very Good	FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes Good	FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes Fair	FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes Poor	FDA International Programs – Objectives, areas of focus, key organizations and outcomes: Cathleen Barnes Did Not Attend
Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith	Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith Very Good	Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith Good	Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith Fair	Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith Poor	Customs and Border Protection – Objective and interfaces with other agencies to prevent the illegal entry of agricultural and food products while facilitating trade: Brenda Smith Did Not Attend
Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala	Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala Very Good	Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala Good	Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala Fair	Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala Poor	Global Regulatory Competencies, Curricula, and Capacity Building: Jerry Wojtala Did Not Attend

Question Title

* 2. Drug and Device Seminar (in order of appearance):

	Very Good	Good	Fair	Poor	Did Not Attend
Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks	Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks Very Good	Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks Good	Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks Fair	Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks Poor	Comparing the U.S. and European System for Regulating Medical Devices: Paul Brooks Did Not Attend
Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman	Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman Very Good	Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman Good	Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman Fair	Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman Poor	Case for Quality Initiative Update: Ricky Rodriguez and Steve Silverman Did Not Attend
Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer	Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer Very Good	Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer Good	Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer Fair	Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer Poor	Interactive Session: Response to Challenging Regulatory Inspection Situations (Working Lunch Presentation): Nancy Singer Did Not Attend
Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman	Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman Very Good	Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman Good	Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman Fair	Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman Poor	Medical Device Single Audit Program Pilot: Paul Brooks and Kimberly Trautman Did Not Attend
Metric, Data & Analysis, & Biometrics: Ricki Chase	Metric, Data & Analysis, & Biometrics: Ricki Chase Very Good	Metric, Data & Analysis, & Biometrics: Ricki Chase Good	Metric, Data & Analysis, & Biometrics: Ricki Chase Fair	Metric, Data & Analysis, & Biometrics: Ricki Chase Poor	Metric, Data & Analysis, & Biometrics: Ricki Chase Did Not Attend
Pharmaceutical Inspection Co-Operation Scheme: Susan Laska	Pharmaceutical Inspection Co-Operation Scheme: Susan Laska Very Good	Pharmaceutical Inspection Co-Operation Scheme: Susan Laska Good	Pharmaceutical Inspection Co-Operation Scheme: Susan Laska Fair	Pharmaceutical Inspection Co-Operation Scheme: Susan Laska Poor	Pharmaceutical Inspection Co-Operation Scheme: Susan Laska Did Not Attend
Biosimilars Regulations: Thomas Berry	Biosimilars Regulations: Thomas Berry Very Good	Biosimilars Regulations: Thomas Berry Good	Biosimilars Regulations: Thomas Berry Fair	Biosimilars Regulations: Thomas Berry Poor	Biosimilars Regulations: Thomas Berry Did Not Attend

Question Title

* 3. Comments:

Thank you for taking the time to participate in this evaluation. Your feedback will be very helpful in planning future conferences!